Manipal Health Enterprises Limited

BSE: MANIPALHOS544847ISIN INE459N01021

Healthcare
Hospital
BSE IPO

BSE listing

Share price

₹714.45+12.45 (+1.77%)

as of 16 Sep 2026

52W high: ₹813.70
52W low: ₹626.00
Off 52W high: -12.20%
1M return: -1.00%
3M return: —
6M return: —
1Y return: —
20D avg volume: 1,28,445
50 DMA: —
200 DMA: —

Key ratios Consolidated

Market cap: ₹93,977 Cr
Current price: ₹714.45
52W high / low: ₹813.70 / ₹626.00
Face value: ₹2.00
P/E: 0.00
P/B: —
EPS (TTM): ₹0.00
Book value / share: —
ROE: —
ROCE: —
Operating margin: —
Net margin: —
Debt / equity: —
Net debt: —
Interest cover: —
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: —

Financials

Metric	Q1 FY27
Income statement
	3,091
	74.56
	2,835
	0.00
	650.14
	462.01
	293.27
	187.25
	1,266
	330.65
	-15.47
	315.18
	71.75
	243.43
	1.96
Key metrics
	795.70
	25.70%
	7.90%

Metric	Q1 FY27
Income statement
	1,048
	40.87
	923.98
	0.00
	214.33
	172.46
	61.59
	64.14
	422.90
	165.19
	-13.43
	151.76
	36.23
	115.53
	0.98
Key metrics
	277.49
	26.50%
	11.00%

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 72.09%

Holder	Type	Holding	Previous	Change
KANGTO INVESTMENTS PTE. LTD	Promoter	23.73%	—	—
MANIPAL GLOBAL HEALTH SERVICES	Promoter	17.65%	—	—
IMPERIUS HEALTHCARE INVESTMENTS PTE. LIMITED	Promoter	15.11%	—	—
TPG SG MAGAZINE PTE. LTD.	Public	9.10%	—	—
KABRU INVESTMENTS PTE. LTD	Promoter	5.19%	—	—
MANIPAL EDUCATION AND MEDICAL GROUP INDIA PRIVATE LIMITED	Promoter Group	4.30%	—	—
CYPRESS HOLDINGS	Promoter Group	3.74%	—	—
SEVENTY SECOND INVESTMENT COMPANY LLC - FDI	Public	3.23%	—	—
MEMG INTERNATIONAL INDIA PRIVATE LIMITED	Promoter Group	1.81%	—	—
AMMAR SDN BHD	Public	1.65%	—	—
NOVO HOLDINGS INVEST ASIA A/S	Public	1.08%	—	—
MANIPAL RESEARCH AND MANAGEMENT SERVICES INTERNATIONAL	Promoter Group	0.39%	—	—
Dr. Ranjan Ramdas Pai	Promoter	0.17%	—	—
MGHS Ventures Limited	Promoter Group	0.00%	—	—
RSP India Trust	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Intimation pursuant to Regulation 30 (12) read with Schedule III of the SEBI Listing Regulations.16 Sep 2026 · Company Update / General
Newspaper Advertisement for information regarding the dispatch of the 16th AGM Notice and other related information including e-voting.5 Sep 2026 · Company Update / Newspaper Publication
Communication to the shareholders on weblink of notice of 16th Annual General Meeting and Annual Report for the financial year 2025-26.4 Sep 2026 · Company Update / General
Annual Report for the financial year 2025-26 along with Notice convening 16th Annual General Meeting.4 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice convening the 16th Annual General Meeting along with Annual Report for the financial year 2025-264 Sep 2026 · AGM/EGM / AGM
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September ....4 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 03, 2026 for Manipal Global ....4 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Newspaper Publication - Information regarding 16th Annual General Meeting3 Sep 2026 · Company Update / Newspaper Publication
Transcript of the Earnings call with Analysts/ Investors27 Aug 2026 · Company Update / Earnings Call Transcript
Audio recording of the Earnings call with Analysts/Investor21 Aug 2026 · Company Update / Analyst / Investor Meet
Newspaper extract of the Un-audited Financial Results of the Company for the Quarter June 30, 2026.21 Aug 2026 · Company Update / Newspaper Publication
Announcement under Regulation 30 (LODR) - Change in Management20 Aug 2026 · Company Update / Change in Management
Intimation for appointment of Statutory Auditors20 Aug 2026 · Company Update / Appointment of Statutory Auditor/s
Press release and Investor Presentation for the Earnings Conference Call with Analysts and Investors of Manipal Health Enterprises Limited (the "Company").20 Aug 2026 · Company Update / Investor Presentation
Press release and Investor Presentation for the Earnings Conference Call with Analysts and Investors.20 Aug 2026 · Company Update / Press Release / Media Release
Board meeting outcome for the Board meeting held on August 20, 202620 Aug 2026 · Result / Financial Results
Board Meeting Outcome for the meeting held on August 20, 2026 For Declaration Of Unaudited Financial Results For The Quarter Ended June 30, 2026.20 Aug 2026 · Board Meeting / Outcome of Board Meeting
Press release titled " Manipal Health Enterprises to Acquire Kinder Women''s Hospital in Bengaluru".18 Aug 2026 · Company Update / Press Release / Media Release
Intimation for executing Business Transfer Agreement with Kindorama Healthcare Private Limited.17 Aug 2026 · Company Update / Acquisition
As per attached letter17 Aug 2026 · Company Update / Analyst / Investor Meet
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Manipal Global Health ....14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Manipal Health Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2026 ,inter alia, to consider and approve the unaudited financial ....14 Aug 2026 · Board Meeting / Board Meeting
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd10 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG10 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Trustee Services Ltd10 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
As enclosed.5 Aug 2026 · Company Update / General
As enclosed.5 Aug 2026 · Company Update / General
As enclosed.5 Aug 2026 · Company Update / General
As enclosed.5 Aug 2026 · Company Update / General
Intimation of Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 20155 Aug 2026 · Insider Trading / SAST / Closure of Trading Window
Trading Members of the Exchange are hereby informed that effective from August 05, 2026, the Equity Shares of Manipal Health Enterprises Ltd (Scrip Code: 544847) are listed and admitted ....5 Aug 2026 · New Listing / New Listing

Board meetings

20 Aug 2026 Board Meeting - Financial Results